Medtronic plc (MDT) EV/FCF Ratio: 22.54x
Is Medtronic plc’s EV/FCF ratio high or low?
Medtronic plc's EV/FCF ratio of 22.54x is 21% below its 5-year average of 28.55x, near the low end of its 5-year range (21.44x–42.56x).
The EV/FCF ratio for Medtronic plc (MDT) is 22.54x as of Wednesday, June 10, 2026. It is below its 12-month average by 17.95% (27.47x).
MDT EV/FCF Ratio Chart
MDT Average EV/FCF Ratio Chart
MDT Current vs Average EV/FCF Ratio Chart
MDT EV/FCF Ratio Metrics
EV/FCF RATIO
22.54x
EV/FCF RATIO AVG TTM
27.47x
EV/FCF RATIO AVG 3Y
27.69x
EV/FCF RATIO AVG 5Y
28.55x
EV/FCF RATIO AVG 10Y
29.65x
EV/FCF RATIO AVG 15Y
25.93x
EV/FCF RATIO AVG 20Y
25.44x
CURRENT VS TTM AVG
-17.95%
CURRENT VS 3Y AVG
-18.59%
CURRENT VS 5Y AVG
-21.05%
CURRENT VS 10Y AVG
-23.97%
CURRENT VS 15Y AVG
-13.06%
CURRENT VS 20Y AVG
-11.39%
MDT Competitors' EV/FCF Ratio
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Medtronic plc (MDT) | — | 22.54x | 27.47x | 27.69x | 28.55x |
| Vertex Pharmaceuticals Incorporated (VRTX) | $110.77B | 29.24x | 32.27x | 28.31x | 25.03x |
| Bristol-Myers Squibb Company (BMY) | $114.14B | 12.52x | 10.43x | 11.38x | 12.31x |
| Elevance Health Inc. (ELV) | $87.43B | 17.20x | 23.51x | 49.67x | 36.13x |
| CVS Health Corporation (CVS) | $125.16B | 26.28x | 27.81x | 26.94x | 21.12x |
| Cigna Corporation (CI) | $78.25B | 13.32x | 17.18x | 14.87x | 15.23x |
| Danaher Corporation (DHR) | $130.25B | 27.20x | 31.97x | 32.30x | 30.49x |
| Regeneron Pharmaceuticals, Inc. (REGN) | $62.59B | 15.69x | 18.48x | 23.61x | 21.61x |
| Pfizer Inc. (PFE) | $146.36B | 22.12x | 19.75x | 27.32x | 21.37x |
| Intuitive Surgical, Inc. (ISRG) | $146.44B | 51.80x | 79.78x | 160.45x | 125.16x |
Cash Flow Valuation Comparison
EV/FCF
22.5x
P/FCF
19.1x
FCF Yield
5.25%
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
- EV/FCF accounts for debt and cash through enterprise value
- P/FCF only considers equity value
- EV/FCF can be compared across companies with different debt levels
- Both measure how the market values cash generation
Medtronic plc EV/FCF Ratio Formula & Definition
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Medtronic plc EV/FCF Ratio FAQ
- What is the EV/FCF ratio for Medtronic plc (MDT)?
- The EV/FCF ratio for MDT stock is 22.54x.
- Is Medtronic plc's EV/FCF ratio high or low?
- Medtronic plc's EV/FCF ratio of 22.54x is 21% below its 5-year average of 28.55x, near the low end of its 5-year range (21.44x–42.56x).
- What is the TTM average EV/FCF ratio for Medtronic plc (MDT)?
- The TTM average EV/FCF ratio for MDT stock is 27.47x.
- What is the 3Y average EV/FCF ratio for Medtronic plc (MDT)?
- The 3Y average EV/FCF ratio for MDT stock is 27.69x.
- What is the 5Y average EV/FCF ratio for Medtronic plc (MDT)?
- The 5Y average EV/FCF ratio for MDT stock is 28.55x.
- What is the 10Y average EV/FCF ratio for Medtronic plc (MDT)?
- The 10Y average EV/FCF ratio for MDT stock is 29.65x.
- What is the 15Y average EV/FCF ratio for Medtronic plc (MDT)?
- The 15Y average EV/FCF ratio for MDT stock is 25.93x.
- What is the 20Y average EV/FCF ratio for Medtronic plc (MDT)?
- The 20Y average EV/FCF ratio for MDT stock is 25.44x.
Medtronic plc EV/FCF Ratio History
| DATE | EV/FCF RATIO |
|---|---|
| 2026-06-02 | 22.54x |
| 2026-06-01 | 22.59x |
| 2026-05-29 | 22.55x |
| 2026-05-28 | 22.97x |
| 2026-05-27 | 23.07x |
| 2026-05-26 | 23.45x |
| 2026-05-22 | 23.69x |
| 2026-05-21 | 23.59x |
| 2026-05-20 | 23.59x |
| 2026-05-19 | 23.69x |
| 2026-05-18 | 23.39x |
| 2026-05-15 | 23.11x |
| 2026-05-14 | 23.30x |
| 2026-05-13 | 23.12x |
| 2026-05-12 | 23.27x |
| 2026-05-11 | 22.73x |
| 2026-05-08 | 23.11x |
| 2026-05-07 | 23.54x |
| 2026-05-06 | 23.45x |
| 2026-05-05 | 23.50x |
| 2026-05-04 | 23.62x |
| 2026-05-01 | 24.03x |
| 2026-04-30 | 24.26x |
| 2026-04-29 | 23.88x |
| 2026-04-28 | 24.48x |
| 2026-04-27 | 24.72x |
| 2026-04-24 | 24.82x |
| 2026-04-23 | 24.93x |
| 2026-04-22 | 24.79x |
| 2026-04-21 | 24.50x |
| 2026-04-20 | 25.22x |
| 2026-04-17 | 25.50x |
| 2026-04-16 | 25.37x |
| 2026-04-15 | 25.72x |
| 2026-04-14 | 25.96x |
| 2026-04-13 | 25.93x |
| 2026-04-10 | 25.74x |
| 2026-04-09 | 25.91x |
| 2026-04-08 | 26.09x |
| 2026-04-07 | 25.55x |
| 2026-04-06 | 25.52x |
| 2026-04-02 | 25.60x |
| 2026-04-01 | 25.47x |
| 2026-03-31 | 25.61x |
| 2026-03-30 | 25.39x |
| 2026-03-27 | 25.73x |
| 2026-03-26 | 25.85x |
| 2026-03-25 | 25.90x |
| 2026-03-24 | 25.59x |
| 2026-03-23 | 25.73x |
| 2026-03-20 | 25.49x |
| 2026-03-19 | 25.66x |
| 2026-03-18 | 25.74x |
| 2026-03-17 | 26.04x |
| 2026-03-16 | 25.99x |
| 2026-03-13 | 25.73x |
| 2026-03-12 | 25.78x |
| 2026-03-11 | 26.16x |
| 2026-03-10 | 26.38x |
| 2026-03-09 | 26.73x |
| 2026-03-06 | 26.62x |
| 2026-03-05 | 27.12x |
| 2026-03-04 | 27.74x |
| 2026-03-03 | 28.00x |
| 2026-03-02 | 28.34x |
| 2026-02-27 | 28.23x |
| 2026-02-26 | 28.08x |
| 2026-02-25 | 27.99x |
| 2026-02-24 | 28.01x |
| 2026-02-23 | 29.73x |
| 2026-02-20 | 29.30x |
| 2026-02-19 | 29.48x |
| 2026-02-18 | 29.70x |
| 2026-02-17 | 29.19x |
| 2026-02-13 | 29.95x |
| 2026-02-12 | 30.29x |
| 2026-02-11 | 30.34x |
| 2026-02-10 | 30.43x |
| 2026-02-09 | 30.48x |
| 2026-02-06 | 30.79x |
| 2026-02-05 | 30.80x |
| 2026-02-04 | 30.53x |
| 2026-02-03 | 30.86x |
| 2026-02-02 | 30.74x |
| 2026-01-30 | 30.81x |
| 2026-01-29 | 30.32x |
| 2026-01-28 | 30.27x |
| 2026-01-27 | 30.25x |
| 2026-01-26 | 30.24x |
| 2026-01-23 | 30.29x |
| 2026-01-22 | 30.41x |
| 2026-01-21 | 30.15x |
| 2026-01-20 | 29.73x |
| 2026-01-16 | 29.27x |
| 2026-01-15 | 29.83x |
| 2026-01-14 | 29.76x |
| 2026-01-13 | 29.19x |
| 2026-01-12 | 29.32x |
| 2026-01-09 | 29.46x |
| 2026-01-08 | 29.75x |
| 2026-01-07 | 30.02x |
| 2026-01-06 | 30.15x |
| 2026-01-05 | 29.42x |
| 2026-01-02 | 29.10x |
| 2025-12-31 | 29.10x |
| 2025-12-30 | 29.25x |
| 2025-12-29 | 29.12x |
| 2025-12-26 | 29.21x |
| 2025-12-24 | 29.40x |
| 2025-12-23 | 29.45x |
| 2025-12-22 | 29.51x |
| 2025-12-19 | 29.74x |
| 2025-12-18 | 29.70x |
| 2025-12-17 | 29.65x |
| 2025-12-16 | 29.51x |
| 2025-12-15 | 29.72x |
| 2025-12-12 | 30.04x |
| 2025-12-11 | 30.01x |
| 2025-12-10 | 30.26x |
| 2025-12-09 | 29.98x |
| 2025-12-08 | 30.39x |
| 2025-12-05 | 30.41x |
| 2025-12-04 | 30.57x |
| 2025-12-03 | 30.56x |
| 2025-12-02 | 30.58x |
| 2025-12-01 | 30.90x |
| 2025-11-28 | 31.39x |
| 2025-11-26 | 31.32x |
| 2025-11-25 | 31.40x |
| 2025-11-24 | 30.20x |
| 2025-11-21 | 29.72x |
| 2025-11-20 | 29.27x |
| 2025-11-19 | 29.51x |
| 2025-11-18 | 29.62x |
| 2025-11-17 | 28.52x |
| 2025-11-14 | 28.42x |
| 2025-11-13 | 28.49x |
| 2025-11-12 | 28.41x |
| 2025-11-11 | 28.31x |
| 2025-11-10 | 27.64x |
| 2025-11-07 | 27.53x |
| 2025-11-06 | 27.01x |
| 2025-11-05 | 27.10x |
| 2025-11-04 | 27.10x |
| 2025-11-03 | 27.05x |
| 2025-10-31 | 27.17x |
| 2025-10-30 | 27.23x |
| 2025-10-29 | 27.42x |
| 2025-10-28 | 27.78x |
| 2025-10-27 | 28.00x |
| 2025-10-24 | 27.89x |
| 2025-10-23 | 28.02x |
| 2025-10-22 | 28.43x |
| 2025-10-21 | 28.41x |
| 2025-10-20 | 28.44x |
| 2025-10-17 | 28.40x |
| 2025-10-16 | 28.22x |
| 2025-10-15 | 28.29x |
| 2025-10-14 | 28.59x |
| 2025-10-13 | 28.35x |
| 2025-10-10 | 28.32x |
| 2025-10-09 | 28.58x |
| 2025-10-08 | 28.91x |
| 2025-10-07 | 29.02x |
| 2025-10-06 | 29.04x |
| 2025-10-03 | 28.87x |
| 2025-10-02 | 28.33x |
| 2025-10-01 | 28.17x |
| 2025-09-30 | 28.27x |
| 2025-09-29 | 27.96x |
| 2025-09-26 | 28.02x |
| 2025-09-25 | 28.04x |
| 2025-09-24 | 28.39x |
| 2025-09-23 | 28.20x |
| 2025-09-22 | 28.12x |
| 2025-09-19 | 28.23x |
| 2025-09-18 | 28.36x |
| 2025-09-17 | 28.11x |
| 2025-09-16 | 28.02x |
| 2025-09-15 | 27.83x |
| 2025-09-12 | 27.98x |
| 2025-09-11 | 28.03x |
| 2025-09-10 | 27.56x |
| 2025-09-09 | 27.99x |
| 2025-09-08 | 27.72x |
| 2025-09-05 | 27.70x |
| 2025-09-04 | 27.69x |
| 2025-09-03 | 27.54x |
| 2025-09-02 | 27.81x |
| 2025-08-29 | 27.68x |
| 2025-08-28 | 27.47x |
| 2025-08-27 | 27.50x |
| 2025-08-26 | 27.53x |
| 2025-08-25 | 27.93x |
| 2025-08-22 | 28.10x |
| 2025-08-21 | 27.70x |
| 2025-08-20 | 28.22x |
| 2025-08-19 | 27.40x |
| 2025-08-18 | 28.12x |
| 2025-08-15 | 28.17x |
| 2025-08-14 | 27.92x |
| 2025-08-13 | 28.15x |
| 2025-08-12 | 27.94x |
| 2025-08-11 | 28.10x |
| 2025-08-08 | 28.14x |
| 2025-08-07 | 27.73x |
| 2025-08-06 | 27.26x |
| 2025-08-05 | 27.34x |
| 2025-08-04 | 27.33x |
| 2025-08-01 | 27.26x |
| 2025-07-31 | 27.48x |
| 2025-07-30 | 27.83x |
| 2025-07-29 | 28.03x |
| 2025-07-28 | 27.91x |
| 2025-07-25 | 28.15x |
| 2025-07-24 | 28.00x |
| 2025-07-23 | 27.92x |
| 2025-07-22 | 27.83x |
| 2025-07-21 | 27.35x |
| 2025-07-18 | 27.33x |
| 2025-07-17 | 27.31x |
| 2025-07-16 | 27.37x |
| 2025-07-15 | 27.23x |
| 2025-07-14 | 27.36x |
| 2025-07-11 | 27.40x |
| 2025-07-10 | 27.27x |
| 2025-07-09 | 27.18x |
| 2025-07-08 | 27.07x |
| 2025-07-07 | 26.84x |
| 2025-07-03 | 27.02x |
| 2025-07-02 | 27.00x |
| 2025-07-01 | 27.11x |
| 2025-06-30 | 26.72x |
| 2025-06-27 | 26.44x |
| 2025-06-26 | 26.47x |
| 2025-06-25 | 26.42x |
| 2025-06-24 | 26.45x |
| 2025-06-23 | 26.42x |
| 2025-06-20 | 26.51x |
| 2025-06-18 | 24.81x |
| 2025-06-17 | 24.91x |
| 2025-06-16 | 25.32x |
| 2025-06-13 | 25.17x |
| 2025-06-12 | 25.46x |
| 2025-06-11 | 25.36x |
| 2025-06-10 | 25.33x |
| 2025-06-09 | 25.21x |
| 2025-06-06 | 25.21x |
| 2025-06-05 | 25.11x |
| 2025-06-04 | 24.78x |
| 2025-06-03 | 24.76x |
| 2025-06-02 | 24.34x |
| 2025-05-30 | 24.16x |
| 2025-05-29 | 24.03x |
| 2025-05-28 | 23.75x |
| 2025-05-27 | 23.74x |
| 2025-05-23 | 23.62x |
| 2025-05-22 | 23.68x |
| 2025-05-21 | 24.50x |
| 2025-05-20 | 24.96x |
Showing the most recent 260 of 5,031 data points. The chart above shows the full history.
Related Metrics
About Medtronic plc
Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Geoffrey Straub Martha